SCHEMBL130843

SCHEMBL130843

Cc1cnn(C)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4553111 0.90 NOS1 (0.38)
SCHEMBL4553110 0.73 AURKB (0.35)
SCHEMBL17809818 0.71 ERN1 (0.45)
SCHEMBL844281 0.71 LRRK2 (0.61)
SCHEMBL1966530 0.71
SCHEMBL18507344 0.69
SCHEMBL8081642 0.69
SCHEMBL3707246 0.69
SCHEMBL22242839 0.69
SCHEMBL4497202 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3766 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250078176-A1 ENVIRONMENTAL ATTRIBUTES FOR NITROGEN CONTAINING CHEMICALS BASF SE (DE) 2025-03-06 US claimed
CN-118681596-B Catalyst for synthesizing ethylene glycol dimethyl ether and preparation method and application thereof 山东东岳氟硅材料有限公司 2024-11-05 CN claimed
CN-118681596-A Catalyst for synthesizing ethylene glycol dimethyl ether and preparation method and application thereof 山东东岳氟硅材料有限公司 2024-09-24 CN claimed
CN-118435582-A Environmental attributes of nitrogen-containing chemicals 巴斯夫欧洲公司 2024-08-02 CN claimed
US-20240207268-A1 PYRAZOLYLPYRIMIDINES FOR TREATING MALIGNANT SOLID TUMOR YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2024-06-27 US claimed
US-20240116910-A1 Heterocycles as WIP1 Inhibitors PMV PHARMACEUTICALS, INC. 2024-04-11 US claimed
EP-4313053-A1 PYRAZOLYLPYRIMIDINES FOR TREATING MALIGNANT SOLID TUMOR Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. (IL) 2024-02-07 EP claimed
US-20230416205-A1 COMPOUNDS, COMPOSITIONS, AND METHODS TENVIE THERAPEUTICS, INC. 2023-12-28 US claimed
EP-4247376-A1 COMPOUNDS, COMPOSITIONS, AND METHODS Denali Therapeutics Inc. (US) 2023-09-27 EP claimed
WO-2023117926-A1 ENVIRONMENTAL ATTRIBUTES FOR NITROGEN CONTAINING CHEMICALS BASF SE (DE) 2023-06-29 WO claimed
US-20050020832-A1 Pyridone, pyridazone and triazone derivatives as lp-pla2 inhibitors SMITHKLINE BEECHAM PLC (GB) 2005-01-27 US claimed
EP-1479671-A1 Pyrimidinone compounds SMITHKLINE BEECHAM PLC (GB) 2004-11-24 EP claimed
US-20040167142-A1 Pyrimidinone compounds SMITHKLINE BEECHAM P.L.C. 2004-08-26 US claimed
EP-1304325-A1 5-(M-CYANOBENZYLAMINO)PYRAZOLE DERIVATIVES Sankyo Company, Limited (JP) 2003-04-23 EP claimed
JP-2002543190-A 2002-12-17 JP claimed
EP-1175408-A1 PYRIMIDINONE COMPOUNDS SMITHKLINE BEECHAM PLC (GB) 2002-01-30 EP claimed
WO-2000066567-A1 PYRIMIDINONE COMPOUNDS SMITHKLINE BEECHAM PLC (GB) 2000-11-09 WO claimed
EP-0350176-B1 Method for preparing pyrazolecarboxylic acid and derivatives NISSAN CHEMICAL IND LTD (JP) 1995-08-30 EP claimed
US-5053517-A PROCESS FOR PREPARING PYRAZOLECARBOXYLIC ACID COMPOUNDS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1991-10-01 US claimed
EP-0350176-A2 Method for preparing pyrazolecarboxylic acid and derivatives NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) 1990-01-10 EP claimed